Multifunctional Gold Nanoparticles Overcome MicroRNA Regulatory Network Mediated-Multidrug Resistant Leukemia
Author:
Publisher
Springer Science and Business Media LLC
Subject
Multidisciplinary
Link
http://www.nature.com/articles/s41598-019-41866-y.pdf
Reference44 articles.
1. Cersosimo, R. J. & Hong, W. K. Epirubicin: a review of the pharmacology, clinical activity, and adverse effects of an adriamycin analogue. J Clin Oncol 4, 425–439, https://doi.org/10.1200/JCO.1986.4.3.425 (1986).
2. Gottesman, M. M., Fojo, T. & Bates, S. E. Multidrug resistance in cancer: role of ATP-dependent transporters. Nat Rev Cancer 2, 48–58, https://doi.org/10.1038/nrc706 (2002).
3. O’Hare, T. et al. AP24534, a pan-BCR-ABL inhibitor for chronic myeloid leukemia, potently inhibits the T315I mutant and overcomes mutation-based resistance. Cancer Cell 16, 401–412, https://doi.org/10.1016/j.ccr.2009.09.028 (2009).
4. Lee, H. J. et al. Drug Resistance via Feedback Activation of Stat3 in Oncogene-Addicted Cancer Cells. Cancer Cell 26, 207–221, https://doi.org/10.1016/j.ccr.2014.05.019 (2014).
5. Brown, R., Curry, E., Magnani, L., Wilhelm-Benartzi, C. S. & Borley, J. Poised epigenetic states and acquired drug resistance in cancer. Nat Rev Cancer 14, 747–753, https://doi.org/10.1038/nrc3819 (2014).
Cited by 32 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Targeting ferroptosis for leukemia therapy: exploring novel strategies from its mechanisms and role in leukemia based on nanotechnology;European Journal of Medical Research;2024-04-09
2. Nanobiosensing Platforms for Early Detection of Cancer;Molecular Biomarkers for Cancer Diagnosis and Therapy;2024
3. Nanoparticles-Mediated Diagnosis of Common Human Diseases: With Special Reference to Gold Nanoparticles;Nanotechnology;2024
4. Metal and metal oxide nanoparticles—applications in medicine;Nanostructured Materials for Biomedical Applications;2024
5. Nanotechnology in leukemia: diagnosis, efficient-targeted drug delivery, and clinical trials;European Journal of Medical Research;2023-12-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3